Eli Lilly said its new lung-cancer drug will cost about $11,430 a patient a month in the U. S.—well above what a group of doctors say is a fair price that reflects what they call the drug’s modest benefit.
from WSJ.com: US Business http://ift.tt/1NLonLx
via IFTTT
No comments:
Post a Comment